CLAIM CARD
This synthesis maps 56 included sources on Extracellular vesicles across 7 outcome classes and 668 cross-study disagreements. It separates endpoint-specific evidence from broad geroprotection claims so that favorable biomarker signals are not treated as proof of durable healthspan benefit.
Evidence grade: exploratory
Contradiction status: none
Publication: 3fa5cd13-7439-4f62-b446-2c8e84c03e7e
Provenance: Derivation Web chain
Citation Support
source_1Jafarzadeh 2025source_2Leung 2025source_3Bolandnazar 2024source_4Wu 2025source_5Kishta 2025